Stay updated on Nivolumab and Relatlimab in MMRd Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.1%
    Check dated 2024-09-04T06:12:19.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The website has been updated to version 2.10.2, replacing the estimated last update posted in version 2.10.0.
    Difference
    0.2%
    Check dated 2024-08-14T01:01:05.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The study has expanded to include a second location in Los Angeles, California, with new contact details for Cedars Sinai Medical Center, while the previous single location and some staff members have been removed.
    Difference
    3%
    Check dated 2024-08-06T23:49:28.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated to include 3 additional interventions/treatments and has moved to revision v2.10.0, replacing the previous v2.9.7.
    Difference
    0.8%
    Check dated 2024-07-23T15:46:22.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T10:09:43.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T17:26:34.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in MMRd Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.